Advaxis, Inc. to Host Dinner Reception For Members of the Gynecologic Oncology Group

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (OTCBB: ADXS, http://www.advaxis.com), a member of the Gynecologic Oncology Group (GOG), will host a dinner on Friday, January 25, 2008 to detail its Phase I/II data for its cervical cancer vaccine, Lovaxin C and review a phase II protocol with the Members of the Cervix and Vaccine Committees in attendance. The GOG is holding its semi-annual meeting this year at the Manchester Grand Hyatt in San Diego, CA, from January 24-26.